These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15359569)

  • 1. Use of biophysical characterization in preformulation development of a heavy-chain fragment of botulinum serotype B: evaluation of suitable purification process conditions.
    Bedu-Addo FK; Johnson C; Jeyarajah S; Henderson I; Advant SJ
    Pharm Res; 2004 Aug; 21(8):1353-61. PubMed ID: 15359569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial purification of recombinant botulinum neurotoxin fragments for pharmaceutical production using hydrophobic charge induction chromatography.
    Weatherly GT; Bouvier A; Lydiard DD; Chapline J; Henderson I; Schrimsher JL; Shepard SR
    J Chromatogr A; 2002 Apr; 952(1-2):99-110. PubMed ID: 12064550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and purification of the heavy-chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotrophic yeast Pichia pastoris.
    Potter KJ; Bevins MA; Vassilieva EV; Chiruvolu VR; Smith T; Smith LA; Meagher MM
    Protein Expr Purif; 1998 Aug; 13(3):357-65. PubMed ID: 9693060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of the N- and C-terminal subdomains of recombinant heavy chain fragment C of botulinum neurotoxin serotype C.
    Huang J; Barent R; Inan M; Gouthro M; Roxas VP; Smith LA; Meagher MM
    Methods Mol Biol; 2007; 389():77-98. PubMed ID: 17951636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and scale-up of a recombinant heavy chain fragment C of botulinum neurotoxin serotype E in Pichia pastoris GS115.
    Dux MP; Barent R; Sinha J; Gouthro M; Swanson T; Barthuli A; Inan M; Ross JT; Smith LA; Smith TJ; Webb R; Loveless B; Henderson I; Meagher MM
    Protein Expr Purif; 2006 Feb; 45(2):359-67. PubMed ID: 16214371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scale-up of the fermentation and purification of the recombinant heavy chain fragment C of botulinum neurotoxin serotype F, expressed in Pichia pastoris.
    Johnson SK; Zhang W; Smith LA; Hywood-Potter KJ; Todd Swanson S; Schlegel VL; Meagher MM
    Protein Expr Purif; 2003 Nov; 32(1):1-9. PubMed ID: 14680933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional analysis of botulinum neurotoxin subunits for pH-dependent membrane channel formation and translocation.
    Chellappan G; Kumar R; Santos E; Goyal D; Cai S; Singh BR
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1510-6. PubMed ID: 26012869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Far-UV circular dichroism reveals a conformational switch in a peptide fragment from the beta-sheet of hen lysozyme.
    Yang JJ; Pikeathly M; Radford SE
    Biochemistry; 1994 Jun; 33(23):7345-53. PubMed ID: 8003499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, purification, and characterization of Clostridium botulinum type B light chain.
    Gilsdorf J; Gul N; Smith LA
    Protein Expr Purif; 2006 Apr; 46(2):256-67. PubMed ID: 16297638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain.
    Zhou Y; Singh BR
    Protein Expr Purif; 2004 Mar; 34(1):8-16. PubMed ID: 14766296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the Degradation Behaviors of a Therapeutic Monoclonal Antibody Associated with pH and Buffer Species.
    Zheng S; Qiu D; Adams M; Li J; Mantri RV; Gandhi R
    AAPS PharmSciTech; 2017 Jan; 18(1):42-48. PubMed ID: 26340951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
    Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms.
    Chen B; Bautista R; Yu K; Zapata GA; Mulkerrin MG; Chamow SM
    Pharm Res; 2003 Dec; 20(12):1952-60. PubMed ID: 14725359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High level expression of the light chain of botulinum neurotoxin serotype C1 and an efficient HPLC assay to monitor its proteolytic activity.
    Rawat R; Ashraf Ahmed S; Swaminathan S
    Protein Expr Purif; 2008 Aug; 60(2):165-9. PubMed ID: 18482846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational stability, reversibility and heat-induced aggregation of α-1-acid glycoprotein.
    Iwura T; Fukuda J; Yamazaki K; Arisaka F
    J Biochem; 2014 Dec; 156(6):345-52. PubMed ID: 25147193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a botulinum fragment C-based ELISA for measuring the humoral immune response in primates.
    Lindsey CY; Smith LA; West MW; Boles JW; Brown JE
    Biologicals; 2003 Mar; 31(1):17-24. PubMed ID: 12623056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey.
    Boles J; West M; Montgomery V; Tammariello R; Pitt ML; Gibbs P; Smith L; LeClaire RD
    Toxicon; 2006 Jun; 47(8):877-84. PubMed ID: 16730042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histidine-phosphocarrier protein of Streptomyces coelicolor folds by a partially folded species at low pH.
    Fernández-Ballester G; Maya J; Martín A; Parche S; Gómez J; Titgemeyer F; Neira JL
    Eur J Biochem; 2003 May; 270(10):2254-67. PubMed ID: 12752445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of calcium on recombinant bovine chromogranin A.
    Angeletti RH; Ali G; Shen N; Gee P; Nieves E
    Protein Sci; 1992 Dec; 1(12):1604-12. PubMed ID: 1304892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor suppressor.
    Johnson CR; Morin PE; Arrowsmith CH; Freire E
    Biochemistry; 1995 Apr; 34(16):5309-16. PubMed ID: 7727392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.